Abcellera Biologics Inc (ABCL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
4,115,401,000
EV to revenue ratio (TTM)
54.2
EV to ebitda
5.3
Financial Performance
Revenue (TTM)
66,170,000
Gross profit (TTM)
-131,597,000
EBITDA
-199,960,000
Profitability
Operating margin (TTM)
-1,550.00%
Profit margin
-248.80%
Return on assets (TTM)
-10.40%
Return on equity (TTM)
-17.30%
Per Share Metrics
Revenue per share (TTM)
0.22
EPS
-0.54
Diluted EPS (TTM)
-0.54
Book value
2.92
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
27.55
PEG ratio
Price to sales ratio (TTM)
62.19
Price to book ratio (TTM)
4.454
Growth
Quarterly earnings growth (YoY)
-76.30%
Quarterly revenue growth (YoY)
45.90%
Analyst Sentiment
Strong buy
1
Buy
8
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
1.322